ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

Smoker Sues NCI To Compel Guideline For CT Scanning.

January 25, 2008

October issue of Business & Regulatory Report included.

November 5, 2004

Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women

July 25, 1980

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999